Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionactin binding

ALKBH4 MYH9 CTNNAL1 GAS7 MACF1 DAAM2 PPP1R9B FHOD3 MICAL3 PLEC KLHL20

1.02e-054799011GO:0003779
GeneOntologyMolecularFunctionATP-dependent activity

KIF13B MYH9 CCT5 ENTPD1 MACF1 CHD2 ATP6V1C2 RFC1 DNAH5 RUVBL2 DDX27 TP53

1.97e-056149012GO:0140657
GeneOntologyMolecularFunctioncytoskeletal protein binding

ALKBH4 KIF13B MYH9 CTNNAL1 CCT5 TTLL4 GAS7 MACF1 DAAM2 PPP1R9B FHOD3 MICAL3 MTCL1 PLEC KLHL20 TBCD

2.90e-0510999016GO:0008092
GeneOntologyMolecularFunctionactin filament binding

MYH9 CTNNAL1 GAS7 MACF1 PPP1R9B FHOD3 PLEC

7.51e-05227907GO:0051015
GeneOntologyMolecularFunctionATP hydrolysis activity

KIF13B CCT5 ENTPD1 MACF1 CHD2 RFC1 DNAH5 RUVBL2 DDX27

1.67e-04441909GO:0016887
GeneOntologyMolecularFunctionprotein demethylase activity

ALKBH4 KDM5B KDM6B

4.00e-0432903GO:0140457
GeneOntologyCellularComponentpolymeric cytoskeletal fiber

KIF13B VIM MYH9 HAUS1 CCT5 TTLL4 GAS7 MACF1 LMNB2 MTCL1 PLEC DNAH5 TUBAL3 TBCD

3.28e-058999114GO:0099513
GeneOntologyCellularComponentnuclear periphery

VIM ATXN3 SMARCC2 LMNB2 RUVBL2 TP53

1.03e-04171916GO:0034399
GeneOntologyCellularComponentsupramolecular fiber

KIF13B VIM MYH9 HAUS1 CCT5 TTLL4 GAS7 MACF1 FHOD3 LMNB2 MTCL1 PLEC DNAH5 TUBAL3 TBCD

1.64e-0411799115GO:0099512
GeneOntologyCellularComponentsupramolecular polymer

KIF13B VIM MYH9 HAUS1 CCT5 TTLL4 GAS7 MACF1 FHOD3 LMNB2 MTCL1 PLEC DNAH5 TUBAL3 TBCD

1.77e-0411879115GO:0099081
GeneOntologyCellularComponentnuclear matrix

VIM ATXN3 SMARCC2 RUVBL2 TP53

3.68e-04140915GO:0016363
GeneOntologyCellularComponentmicrotubule

KIF13B HAUS1 CCT5 TTLL4 MACF1 MTCL1 DNAH5 TUBAL3 TBCD

5.23e-04533919GO:0005874
GeneOntologyCellularComponentmicrotubule organizing center

HMBOX1 EVI5 VIM CCDC8 AKAP9 HAUS1 CCT5 ERC1 TTLL4 RUVBL2 TP53 TBCD

6.26e-049199112GO:0005815
GeneOntologyCellularComponentactin cytoskeleton

MYH9 LPXN GAS7 MACF1 PPP1R9B FHOD3 MYH16 CGNL1 KLHL20

9.07e-04576919GO:0015629
GeneOntologyCellularComponentorganelle outer membrane

TMEM53 ACACB ASL SPART PLEC MLXIP

1.38e-03279916GO:0031968
GeneOntologyCellularComponentouter membrane

TMEM53 ACACB ASL SPART PLEC MLXIP

1.43e-03281916GO:0019867
GeneOntologyCellularComponentneuromuscular junction

MYH9 LAMC1 PDZRN3 LARGE1

1.46e-03112914GO:0031594
GeneOntologyCellularComponentcontractile ring

ALKBH4 MYH9

1.65e-0314912GO:0070938
GeneOntologyCellularComponentcentrosome

HMBOX1 EVI5 CCDC8 AKAP9 HAUS1 CCT5 ERC1 RUVBL2 TP53 TBCD

1.89e-037709110GO:0005813
GeneOntologyCellularComponentmyosin complex

MYH9 MYH16 CGNL1

2.18e-0359913GO:0016459
GeneOntologyCellularComponentPML body

HMBOX1 ZMYM2 KLHL20 TP53

2.18e-03125914GO:0016605
DomainBRCT_dom

MDC1 PES1 SMARCC2 RFC1

8.26e-0628874IPR001357
DomainBRCT

MDC1 PES1 RFC1

8.96e-0519873PF00533
DomainBRCT

MDC1 PES1 RFC1

1.41e-0422873SM00292
Domain-

MDC1 PES1 RFC1

1.62e-04238733.40.50.10190
DomainBRCT

MDC1 PES1 RFC1

2.35e-0426873PS50172
Domain-

MACF1 PLEC

3.18e-0468723.90.1290.10
DomainPlectin_repeat

MACF1 PLEC

4.44e-047872IPR001101
DomainPlectin

MACF1 PLEC

4.44e-047872PF00681
DomainPLEC

MACF1 PLEC

4.44e-047872SM00250
DomainChromo/shadow_dom

SMARCC2 CHD2 CBX8

4.81e-0433873IPR000953
DomainCHROMO

SMARCC2 CHD2 CBX8

4.81e-0433873SM00298
DomainDAD_dom

DAAM2 FHOD3

5.90e-048872IPR014767
DomainDAD

DAAM2 FHOD3

5.90e-048872PS51231
DomainGBD/FH3_dom

DAAM2 FHOD3

1.15e-0311872IPR014768
DomainGBD_FH3

DAAM2 FHOD3

1.15e-0311872PS51232
DomainFH2

DAAM2 FHOD3

2.17e-0315872PS51444
DomainFH2_Formin

DAAM2 FHOD3

2.17e-0315872IPR015425
DomainFH2

DAAM2 FHOD3

2.17e-0315872PF02181
DomainFH2

DAAM2 FHOD3

2.17e-0315872SM00498
DomainGlobin-like

VIM CYGB

2.47e-0316872IPR009050
DomainUIM

ATXN3 USP37

3.13e-0318872PF02809
DomainChromodomain_CS

CHD2 CBX8

3.13e-0318872IPR023779
DomainMyosin_tail_1

MYH9 CGNL1

3.13e-0318872PF01576
DomainMyosin_tail

MYH9 CGNL1

3.13e-0318872IPR002928
DomainCH

MACF1 MICAL3 PLEC

3.46e-0365873SM00033
DomainUIM

ATXN3 USP37

4.25e-0321872SM00726
DomainCH

MACF1 MICAL3 PLEC

4.27e-0370873PF00307
Domain-

MACF1 MICAL3 PLEC

4.44e-03718731.10.418.10
DomainCH

MACF1 MICAL3 PLEC

4.80e-0373873PS50021
DomainARM-type_fold

RANBP17 USP34 INTS1 DAAM2 FHOD3 TBCD

5.04e-03339876IPR016024
DomainActinin_actin-bd_CS

MACF1 PLEC

5.09e-0323872IPR001589
DomainACTININ_2

MACF1 PLEC

5.09e-0323872PS00020
DomainACTININ_1

MACF1 PLEC

5.09e-0323872PS00019
DomainCH-domain

MACF1 MICAL3 PLEC

5.18e-0375873IPR001715
DomainChromo_domain

CHD2 CBX8

5.54e-0324872IPR023780
DomainJmjC

KDM5B KDM6B

5.54e-0324872PF02373
Pubmed

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.

VIM ACACB MDC1 PES1 SMARCC2 MACF1 CGNL1 PLEC CDC5L RFC1 DNAH5 GOLGB1 TP53

4.99e-14234911336243803
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

CUL4A FSIP2 KIF13B VIM KDM5B CCDC8 AKAP9 ERC1 PPFIBP1 LAMC1 MACF1 MTCL1 CGNL1 PLEC MLXIP RAPGEF2 GOLGB1 TP53

8.89e-12861911836931259
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

USP34 MYH9 RBM25 CCT5 UBR5 MDC1 PES1 INTS1 SMARCC2 MACF1 CHD2 LMNB2 PLEC RFC1 DDX27 TP53

1.41e-11653911622586326
Pubmed

WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.

VIM MDC1 PES1 INTS1 ZMYM2 SMARCC2 CHD2 CDC5L RFC1 RUVBL2 DDX27 CBX8 TP53

3.59e-11394911327248496
Pubmed

Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.

MYH9 RBM25 MDC1 PES1 INTS1 ZMYM2 SMARCC2 PLEC RFC1 RUVBL2 TUBAL3

1.43e-10271911132433965
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

CUL4A USP34 MYH9 RBM25 CCT5 UBR5 MDC1 PES1 INTS1 SMARCC2 CHD2 LMNB2 PLEC CDC5L RFC1 RUVBL2 TP53

1.06e-091014911732416067
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

CCDC8 RBM25 CCT5 UBR5 MDC1 PES1 INTS1 SMARCC2 LAMC1 MACF1 LMNB2 PLEC CDC5L RUVBL2 DDX27 GOLGB1 TP53

1.22e-091024911724711643
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

KIF13B VIM MYH9 AKAP9 UBR5 ERC1 ZMYM2 SMARCC2 MACF1 PPP1R9B FYCO1 LMNB2 MTCL1 CDC5L RAPGEF2 GOLGB1

3.94e-09963911628671696
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

ACACB HAUS1 CCT5 UBR5 ERC1 PPFIBP1 MICAL3 CGNL1 PLEC MLXIP RUVBL2 DDX27 PDZRN3 CBX8 TP53

6.01e-09853911528718761
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

VIM USP34 KDM5B MYH9 ACACB UBR5 ERC1 ZMYM2 LAMC1 PLEC GOLGB1

1.33e-08418911134709266
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

VIM KDM5B MYH9 RBM25 NOL12 PES1 INTS1 ZMYM2 SMARCC2 MACF1 CHD2 LMNB2 PLEC CDC5L RUVBL2 CBX8

2.02e-081082911638697112
Pubmed

MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.

SEMA3A MYH9 ERC1 MDC1 PES1 NBPF10 ZMYM2 MACF1 CDC5L TP53

3.62e-08358911032460013
Pubmed

N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.

VIM MYH9 ERC1 PPFIBP1 MACF1 MICAL3 LMNB2 PLEC CDC5L GOLGB1

3.81e-08360911033111431
Pubmed

MYC multimers shield stalled replication forks from RNA polymerase.

VIM MYH9 RBM25 CCT5 MDC1 PES1 ZMYM2 SMARCC2 ATP6V1C2 LMNB2 PLEC CDC5L RFC1 RUVBL2 DDX27

4.23e-08989911536424410
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

KIF13B USP34 UBR5 ERC1 VPS50 ZMYM2 SPART MACF1 CGNL1 RUVBL2 GOLGB1 TP53

4.57e-08588911238580884
Pubmed

Functional proteomics mapping of a human signaling pathway.

EVC2 UBR5 L1TD1 ZMYM2 SPART LAMC1 MACF1 PPP1R9B PLEC GOLGB1 TP53 TBCD

4.83e-08591911215231748
Pubmed

LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair.

VIM UBR5 SMARCC2 RFC1 RUVBL2 TP53

6.47e-087991626446488
Pubmed

VCP phosphorylation-dependent interaction partners prevent apoptosis in Helicobacter pylori-infected gastric epithelial cells.

VIM HAUS1 CCT5 UBR5 VPS50 ATXN3 LMNB2 PLEC TP53

7.00e-0828891923383273
Pubmed

The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.

CUL4A USP34 AKAP9 ACACB UBR5 ERC1 MDC1 SMARCC2 CDC5L CBX8

9.26e-08396911026687479
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

AKAP9 UBR5 ERC1 MACF1 DAAM2 CACNA1H MICAL3 MTCL1 MLXIP LARGE1

1.19e-07407911012693553
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

VIM MYH9 ACACB ERC1 PES1 ZMYM2 SPART MACF1 PPP1R9B CGNL1 CDC5L RFC1 GOLGB1 TP53

1.45e-07934911433916271
Pubmed

SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.

VIM MYH9 RBM25 UBR5 PES1 LMNB2 PLEC CDC5L RFC1 RUVBL2 DDX27 TP53

1.47e-07655911235819319
Pubmed

ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.

VIM MYH9 RBM25 MDC1 PES1 MACF1 PPP1R9B LMNB2 PLEC CDC5L RUVBL2 TP53

1.59e-07660911232780723
Pubmed

Charting the landscape of tandem BRCT domain-mediated protein interactions.

HMBOX1 RBM25 UBR5 MDC1 PPP1R9B MICAL3 CDC5L ALDH9A1 RUVBL2 CBX8 TP53 LCMT1

1.87e-07670911222990118
Pubmed

Barrier-to-autointegration factor proteome reveals chromatin-regulatory partners.

CUL4A EVC2 MDC1 SMARCC2 LMNB2

1.91e-074991519759913
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

CUL4A USP34 RBM25 UBR5 ERC1 NOL12 VPS50 L1TD1 SMARCC2 GAS7 MACF1 RAPGEF2 RUVBL2 PDZRN3 TP53

2.01e-071116911531753913
Pubmed

In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.

CUL4A VIM USP34 CCDC8 RBM25 CCT5 UBR5 MTCL1 CDC5L RFC1 USP37 RUVBL2 DDX27 TP53

2.31e-07971911433306668
Pubmed

BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.

CUL4A VIM TAOK3 MYH9 RBM25 ACACB CCT5 PES1 INTS1 CHD2 PLEC CDC5L RFC1 RUVBL2 DDX27 TUBAL3

2.96e-071318911630463901
Pubmed

Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin.

VIM RBM25 CCT5 SMARCC2 PLEC CDC5L RUVBL2

3.38e-0717091716159877
Pubmed

Defining the human deubiquitinating enzyme interaction landscape.

CUL4A KIF13B KDM5B MYH9 HAUS1 UBR5 ATXN3 PPP1R9B MTCL1 PLEC ALDH9A1 USP37 KLHL20 TP53

3.50e-071005911419615732
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

VIM MYH9 CCT5 INTS1 SMARCC2 MACF1 MTCL1 PLEC CDC5L RUVBL2 GOLGB1

3.71e-07582911120467437
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

VIM MYH9 CCT5 UBR5 MDC1 PES1 SMARCC2 MACF1 CHD2 LMNB2 PLEC CDC5L RFC1 ALDH9A1 RUVBL2 DDX27

4.19e-071353911629467282
Pubmed

The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation.

VIM MYH9 SUSD5 NOL12 PES1 LMNB2 PLEC CDC5L DDX27 TUBAL3 TP53

5.34e-07604911137616343
Pubmed

CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.

CUL4A VIM MYH9 PDP2 MTCL1 PLEC RFC1

5.35e-0718291731067453
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

VIM CCDC8 CTNNAL1 AKAP9 HAUS1 CCT5 ERC1 PES1 PDP2 PPP1R9B MICAL3 CDC5L DDX27 CBX8

5.84e-071049911427880917
Pubmed

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

MYH9 AKAP9 UBR5 ERC1 PPFIBP1 SPART FYCO1 ALDH9A1 DDX27 GOLGB1 CBX8 TP53

6.52e-07754911233060197
Pubmed

Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.

CCDC8 PPFIBP1 PES1 MACF1 FHOD3 PLEC RFC1 DDX27 TP53 LARGE1

7.28e-07496911031343991
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

CUL4A VIM MYH9 CCT5 UBR5 ERC1 PPFIBP1 MDC1 SMARCC2 MACF1 MTCL1 PLEC CDC5L RFC1 RUVBL2 GOLGB1

7.58e-071415911628515276
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

MYH9 RBM25 CCT5 ERC1 PPFIBP1 MDC1 PES1 PPP1R9B LMNB2 PLEC CDC5L RFC1 RUVBL2 DDX27 CBX8

9.02e-071257911536526897
Pubmed

Oct4 links multiple epigenetic pathways to the pluripotency network.

CCT5 MDC1 L1TD1 ZMYM2 SMARCC2 LAMC1 RFC1

1.11e-0620391722083510
Pubmed

Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.

VIM MYH9 MDC1 PES1 INTS1 SMARCC2 LMNB2 PLEC CDC5L RUVBL2 DDX27

1.13e-06652911131180492
Pubmed

TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.

CUL4A VIM MYH9 RBM25 CCT5 NOL12 MDC1 PES1 PPP1R9B PLEC CDC5L DDX27 TUBAL3

1.15e-06949911336574265
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

VIM USP34 KDM5B ERC1 PPFIBP1 ZMYM2 GAS7 MACF1 DAAM2 PLEC RAPGEF2 KDM6B DDX27 DKK3 STAT5B

1.19e-061285911535914814
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

CUL4A HMBOX1 VIM MYH9 RBM25 MDC1 INTS1 ZMYM2 CHD2 LMNB2 CDC5L MLXIP RFC1 RUVBL2 CBX8

1.29e-061294911530804502
Pubmed

Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.

VIM MYH9 AKAP9 CCT5 ERC1 LPXN SMARCC2 MACF1 DAAM2 FYCO1 PLEC RUVBL2

1.32e-06807911230575818
Pubmed

Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.

RBM25 MDC1 PES1 SMARCC2 CHD2 RFC1 RUVBL2 DDX27 CBX8 TP53

1.39e-06533911030554943
Pubmed

Phosphoproteome analysis of the human mitotic spindle.

EVI5 VIM UBR5 NOL12 MTCL1 PLEC RFC1

1.39e-0621091716565220
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

VIM MYH9 CCT5 UBR5 ERC1 SPART MACF1 MICAL3 PLEC CDC5L RFC1 ALDH9A1 RUVBL2 TP53

1.70e-061149911435446349
Pubmed

Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.

AKAP9 UBR5 MACF1 PLEC GOLGB1

1.75e-067691527542412
Pubmed

Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome.

VIM MYH9 CCT5 SMARCC2 LAMC1 PLEC RFC1

1.84e-0621991731353912
Pubmed

Filament-associated TSGA10 protein is expressed in professional antigen presenting cells and interacts with vimentin.

VIM MYH9 PLEC

2.05e-061091320797700
Pubmed

Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.

VIM MYH9 RBM25 CCT5 PES1 LMNB2 CDC5L RFC1 TP53

2.44e-0644191931239290
Pubmed

The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability.

VIM MYH9 CCT5 ERC1 LMNB2 PLEC RUVBL2 TP53

2.48e-0632891823398456
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

MYH9 RBM25 CTNNAL1 CCT5 ERC1 PPFIBP1 SPART MACF1 MICAL3 RUVBL2 GOLGB1

2.49e-06708911139231216
Pubmed

Fyn Regulates Binding Partners of Cyclic-AMP Dependent Protein Kinase A.

VIM MYH9 AKAP9 CCT5 TUBAL3

2.55e-068291530274258
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

VIM MYH9 RBM25 AKAP9 CCT5 PES1 SMARCC2 LAMC1 CHD2 PLEC RFC1 RUVBL2 DDX27 CBX8 TP53

2.63e-061371911536244648
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

AKAP9 ACACB UBR5 ERC1 PPFIBP1 PPP1R9B MTCL1 RAPGEF2 RUVBL2

2.68e-0644691924255178
Pubmed

ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.

MDC1 ZMYM2 SMARCC2 CDC5L RUVBL2 CBX8

2.87e-0615091628242625
Pubmed

Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.

CCDC8 AKAP9 ERC1 MACF1 CGNL1 PLEC

3.10e-0615291634299191
Pubmed

PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.

MYH9 RBM25 MDC1 INTS1 SMARCC2 CDC5L RFC1 RUVBL2

3.23e-0634091824332808
Pubmed

Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2.

AKAP9 UBR5 CDC5L RFC1 RUVBL2

3.42e-068791517148452
Pubmed

BCAS3 exhibits oncogenic properties by promoting CRL4A-mediated ubiquitination of p53 in breast cancer.

CUL4A VIM TP53

3.75e-061291334240781
Pubmed

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.

HMBOX1 VIM MYH9 RBM25 MDC1 PES1 SMARCC2 CDC5L RFC1 DDX27

4.28e-06605911028977666
Pubmed

SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.

CUL4A MYH9 SMARCC2 LMNB2 CDC5L RFC1 PDZRN3

4.41e-0625091733536335
Pubmed

An Interaction Landscape of Ubiquitin Signaling.

UBR5 VPS50 ATXN3 PDP2 LAMC1 MACF1 PLEC RFC1 USP37

4.94e-0648191928190767
Pubmed

Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.

SEMA3A VIM USP34 TAOK3 MYH9 RBM25 TMEM53 AKAP9 INTS1 SMARCC2 PDP2 LAMC1 CHD2 PLEC PDZRN3

5.22e-061451911530550785
Pubmed

HEY1 functions are regulated by its phosphorylation at Ser-68.

VIM AKAP9 CCT5 PLEC TP53

5.28e-069591527129302
Pubmed

A human MAP kinase interactome.

MYH9 ZMYM2 GAS7 MACF1 CGNL1 PLEC RAPGEF2 DDX27 GOLGB1

5.37e-0648691920936779
Pubmed

Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.

VIM MYH9 RBM25 TTLL4 PES1 SMARCC2 CDC5L RFC1 TP53

5.37e-0648691930940648
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

KIF13B PPFIBP1 GAS7 MACF1 MICAL3 CGNL1 CDC5L USP37 PDZRN3

6.02e-0649391915368895
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

VIM USP34 CCDC8 MYH9 ACACB CCT5 UBR5 PPFIBP1 CGNL1 RAPGEF2 GOLGB1

6.02e-06777911135844135
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

ALKBH4 USP34 B4GALNT4 TTLL4 INTS1 CACNA1H MICAL3 FYCO1 LMNB2 PLEC MLXIP KDM6B TBCD

6.06e-061105911335748872
Pubmed

A proteome-scale map of the SARS-CoV-2-human contactome.

VIM AKAP9 PPFIBP1 SPART DAAM2 KLHL20

6.52e-0617391636217029
Pubmed

Plectin deficiency affects precursor formation and dynamics of vimentin networks.

VIM PLEC

6.77e-06291218848541
Pubmed

Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells.

SEMA3A MICAL3

6.77e-06291230587593
Pubmed

p53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons.

ATXN3 TP53

6.77e-06291221092747
Pubmed

Oxidation and nitrosylation of cysteines proximal to the intermediate filament (IF)-binding site of plectin: effects on structure and vimentin binding and involvement in IF collapse.

VIM PLEC

6.77e-06291217224453
Pubmed

Actin-binding domain of mouse plectin. Crystal structure and binding to vimentin.

VIM PLEC

6.77e-06291215128297
Pubmed

EDD induces cell cycle arrest by increasing p53 levels.

UBR5 TP53

6.77e-06291222374670
Pubmed

Human Herpesvirus-6 U14 Induces Cell-Cycle Arrest in G2/M Phase by Associating with a Cellular Protein, EDD.

UBR5 TP53

6.77e-06291226340541
Pubmed

Variable metastatic potentials correlate with differential plectin and vimentin expression in syngeneic androgen independent prostate cancer cells.

VIM PLEC

6.77e-06291223717685
Pubmed

CircMYH9 drives colorectal cancer growth by regulating serine metabolism and redox homeostasis in a p53-dependent manner.

MYH9 TP53

6.77e-06291234496888
Pubmed

NFBD1/MDC1 associates with p53 and regulates its function at the crossroad between cell survival and death in response to DNA damage.

MDC1 TP53

6.77e-06291217535811
Pubmed

Fully functional, naturally occurring and C-terminally truncated variant human immunodeficiency virus (HIV) Vif does not bind to HIV Gag but influences intermediate filament structure.

VIM PLEC

6.77e-06291211172097
Pubmed

Spinophilin loss contributes to tumorigenesis in vivo.

PPP1R9B TP53

6.77e-06291221670604
Pubmed

Chromobox homolog 8 is a predictor of muscle invasive bladder cancer and promotes cell proliferation by repressing the p53 pathway.

CBX8 TP53

6.77e-06291228837252
Pubmed

p53 interaction with JMJD3 results in its nuclear distribution during mouse neural stem cell differentiation.

KDM6B TP53

6.77e-06291221483786
Pubmed

DNA damage induced activation of Cygb stabilizes p53 and mediates G1 arrest.

CYGB TP53

6.77e-06291225269893
Pubmed

High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival.

CUL4A TP53

6.77e-06291230562757
Pubmed

JARID1B modulates lung cancer cell proliferation and invasion by regulating p53 expression.

KDM5B TP53

6.77e-06291225877751
Pubmed

The tumor suppressor capability of p53 is dependent on non-muscle myosin IIA function in head and neck cancer.

MYH9 TP53

6.77e-06291228160562
Pubmed

Keeping the vimentin network under control: cell-matrix adhesion-associated plectin 1f affects cell shape and polarity of fibroblasts.

VIM PLEC

6.77e-06291220702585
Pubmed

New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.

VIM MYH9 CCT5 MDC1 NBPF10 CACNA1H CDC5L RUVBL2 TUBAL3

8.27e-0651391925798074
Pubmed

Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.

FSIP2 RBM25 ERC1 MDC1 SPART SMARCC2 CDC5L TP53

1.04e-0539991835987950
Pubmed

Proteomic analysis of DZIP3 interactome and its role in proliferation and metastasis in gastric cancer cells.

VIM CDC5L RUVBL2 TP53

1.16e-055391436841324
Pubmed

In vitro nuclear interactome of the HIV-1 Tat protein.

MYH9 PES1 SMARCC2 CDC5L RFC1 RUVBL2

1.29e-0519591619454010
Pubmed

Mapping the mammalian ribosome quality control complex interactome using proximity labeling approaches.

MYH9 RBM25 ACACB ATXN3 TP53 TBCD

1.58e-0520291629540532
Pubmed

Hrd1-mediated ACLY ubiquitination alleviate NAFLD in db/db mice.

VIM MYH9 PLEC

1.63e-051991332888949
Pubmed

LIM-domain transcription complexes interact with ring-finger ubiquitin ligases and thereby impact islet β-cell function.

SMARCC2 CDC5L RUVBL2

1.63e-051991331186351
Pubmed

ABCE1 is a highly conserved RNA silencing suppressor.

CUL4A VIM MACF1 LMNB2 TP53 TBCD

1.67e-0520491625659154
InteractionKDM1A interactions

VIM USP34 KDM5B MYH9 AKAP9 ACACB HAUS1 UBR5 ERC1 VPS50 ZMYM2 SMARCC2 LAMC1 FYCO1 PLEC CDC5L RUVBL2 GOLGB1 TP53

2.69e-089419019int:KDM1A
InteractionSIRT7 interactions

CUL4A USP34 MYH9 RBM25 CCT5 UBR5 MDC1 PES1 INTS1 SMARCC2 MACF1 CHD2 LMNB2 PLEC RFC1 DDX27 TP53

2.75e-087449017int:SIRT7
InteractionEED interactions

CUL4A VIM MYH9 RBM25 ACACB CCT5 MDC1 PES1 INTS1 ZMYM2 SMARCC2 LAMC1 MACF1 PPP1R9B CHD2 LMNB2 CGNL1 PLEC CDC5L RUVBL2 DDX27 CBX8 TBCD

5.90e-0814459023int:EED
InteractionACTR1A interactions

MYH9 RBM25 CCT5 UBR5 VPS50 ATXN3 SMARCC2 PPP1R9B PLEC CDC5L

4.03e-072749010int:ACTR1A
InteractionKIF5B interactions

VIM MYH9 CCT5 L1TD1 SPART FYCO1 CDC5L RAPGEF2 KDM6B RUVBL2 TP53

4.28e-073489011int:KIF5B
InteractionSLFN11 interactions

VIM MYH9 CCT5 SMARCC2 LMNB2 CDC5L RFC1 KDM6B RUVBL2 PDZRN3 TP53

9.18e-073769011int:SLFN11
InteractionSUZ12 interactions

CUL4A AKAP9 PES1 INTS1 SMARCC2 PPP1R9B CHD2 LMNB2 PLEC CDC5L RUVBL2 KLHL20 CBX8 TP53

9.67e-076449014int:SUZ12
InteractionYWHAZ interactions

FSIP2 KIF13B VIM KDM5B CCDC8 MYH9 AKAP9 ERC1 PPFIBP1 MDC1 LAMC1 MACF1 PPP1R9B CGNL1 PLEC CDC5L MLXIP RAPGEF2 ALDH9A1 TP53

1.11e-0613199020int:YWHAZ
InteractionATOH1 interactions

CUL4A AKAP9 UBR5 MACF1 PLEC GOLGB1

1.54e-0680906int:ATOH1
InteractionHDAC1 interactions

CUL4A VIM KDM5B MYH9 RBM25 AKAP9 ACACB CCT5 UBR5 ERC1 ZMYM2 SMARCC2 PLEC RFC1 USP37 RUVBL2 GOLGB1 TP53

1.61e-0611089018int:HDAC1
InteractionPOU5F1 interactions

CUL4A USP34 ACACB CCT5 UBR5 ERC1 MDC1 L1TD1 ZMYM2 SMARCC2 LAMC1 CDC5L RFC1

1.89e-065849013int:POU5F1
InteractionYWHAG interactions

CUL4A KIF13B VIM KDM5B CCDC8 AKAP9 ERC1 PPFIBP1 MACF1 PPP1R9B MTCL1 CGNL1 CDC5L MLXIP RAPGEF2 USP37 RUVBL2 DDX27 TP53

2.06e-0612489019int:YWHAG
InteractionOBSL1 interactions

CCDC8 RBM25 CCT5 PPFIBP1 MDC1 PES1 SMARCC2 MACF1 LMNB2 PLEC CDC5L RFC1 RUVBL2 DDX27 GOLGB1 TP53

2.17e-069029016int:OBSL1
InteractionFBXO42 interactions

KIF13B CCT5 ERC1 VPS50 SPART MACF1 RUVBL2 GOLGB1 TP53

2.37e-06259909int:FBXO42
InteractionCCDC68 interactions

AKAP9 PPP1R9B FYCO1 PLEC

2.56e-0622904int:CCDC68
InteractionKIF23 interactions

CUL4A KIF13B VIM MYH9 RBM25 UBR5 ERC1 PES1 MACF1 PPP1R9B MICAL3 FYCO1 LMNB2 MTCL1 PLEC RFC1 DDX27

2.69e-0610319017int:KIF23
InteractionDPPA4 interactions

CUL4A VIM USP34 ACACB UBR5 MDC1 SMARCC2

3.10e-06140907int:DPPA4
InteractionNUP43 interactions

CUL4A FSIP2 USP34 ACACB CCT5 UBR5 MDC1 ZMYM2 RFC1 RAPGEF2 DDX27 CBX8 TP53

3.98e-066259013int:NUP43
InteractionPCGF1 interactions

USP34 AKAP9 ACACB ERC1 MDC1 SMARCC2 CBX8 TP53

4.23e-06208908int:PCGF1
InteractionDCTN2 interactions

RBM25 AKAP9 HAUS1 ERC1 VPS50 ATXN3 SMARCC2 PPP1R9B CDC5L TP53

4.26e-063569010int:DCTN2
InteractionUSP7 interactions

CUL4A VIM MYH9 ACACB MDC1 PES1 ATXN3 SMARCC2 MACF1 CGNL1 PLEC CDC5L RFC1 KDM6B DNAH5 RUVBL2 GOLGB1 CBX8 TP53

4.32e-0613139019int:USP7
InteractionEFTUD2 interactions

CUL4A VIM CCDC8 MYH9 CCT5 UBR5 ERC1 PPFIBP1 MDC1 ATXN3 SMARCC2 MACF1 MTCL1 PLEC CDC5L RFC1 USP37 RUVBL2 GOLGB1 TP53

4.70e-0614499020int:EFTUD2
InteractionSNX2 interactions

CCDC8 TAOK3 ERC1 LAMC1 CDC5L RUVBL2 TP53 TBCD

5.21e-06214908int:SNX2
InteractionKPNB1 interactions

CUL4A VIM CCDC8 UBR5 MDC1 ATXN3 SPART SMARCC2 PPP1R9B CDC5L RUVBL2 TP53

5.35e-065449012int:KPNB1
InteractionRNF2 interactions

KIF13B VIM AKAP9 CCT5 UBR5 PES1 SMARCC2 PPP1R9B LMNB2 CDC5L RUVBL2 DDX27 TUBAL3 CBX8 TP53

6.28e-068669015int:RNF2
InteractionKCNA3 interactions

VIM MYH9 RBM25 CTNNAL1 CCT5 ERC1 PPFIBP1 SPART MACF1 MICAL3 FYCO1 CHD2 DNAH5 RUVBL2 GOLGB1

6.73e-068719015int:KCNA3
InteractionYWHAQ interactions

KIF13B VIM KDM5B CCDC8 MYH9 ERC1 PPFIBP1 MACF1 CGNL1 PLEC CDC5L MLXIP RFC1 RAPGEF2 RUVBL2 GOLGB1 TBCD

7.91e-0611189017int:YWHAQ
InteractionNANOG interactions

CUL4A USP34 AKAP9 ACACB ERC1 INTS1 L1TD1 ZMYM2 RUVBL2 DDX27 TP53

9.72e-064819011int:NANOG
InteractionPPP2CA interactions

CUL4A MYH9 CCT5 PPFIBP1 MDC1 INTS1 PPP1R9B TP53 TBCD STAT5B LCMT1

1.03e-054849011int:PPP2CA
InteractionGAPDH interactions

CUL4A CCDC8 MYH9 CCT5 TTLL4 ATXN3 GAS7 LAMC1 MACF1 PPP1R9B CDC5L RFC1 TP53

1.08e-056869013int:GAPDH
InteractionMEN1 interactions

KIF13B VIM MYH9 RBM25 UBR5 NOL12 MDC1 PES1 INTS1 ZMYM2 SMARCC2 RFC1 RUVBL2 DDX27 CBX8 TP53

1.16e-0510299016int:MEN1
InteractionCASQ2 interactions

CCDC8 MYH9 PES1 PPP1R9B PLEC

1.23e-0567905int:CASQ2
InteractionZBTB44 interactions

AKAP9 FYCO1 RFC1 KLHL20 TP53

1.23e-0567905int:ZBTB44
InteractionRCOR1 interactions

USP34 KDM5B MYH9 ACACB UBR5 ERC1 VPS50 ZMYM2 SMARCC2 PLEC RUVBL2

1.25e-054949011int:RCOR1
InteractionMECP2 interactions

VIM KDM5B MYH9 RBM25 NOL12 PES1 INTS1 ZMYM2 SMARCC2 MACF1 CHD2 LMNB2 PLEC CDC5L RUVBL2 KLHL20 CBX8 TP53

1.29e-0512879018int:MECP2
InteractionSOX2 interactions

CUL4A VIM USP34 KDM5B CCT5 UBR5 PES1 INTS1 ATXN3 L1TD1 ZMYM2 SMARCC2 MACF1 PPP1R9B LMNB2 RFC1 ALDH9A1 RUVBL2 DDX27

1.35e-0514229019int:SOX2
InteractionCAPZB interactions

VIM CCDC8 TAOK3 MYH9 CCT5 UBR5 ERC1 PPFIBP1 MDC1 SPART PPP1R9B MTCL1 CDC5L ALDH9A1 RUVBL2 TP53

1.47e-0510499016int:CAPZB
InteractionH2AC4 interactions

CUL4A VIM UBR5 NOL12 PES1 CHD2 RFC1 DNAH5 DDX27 CBX8 TP53

1.56e-055069011int:H2AC4
InteractionRBBP7 interactions

CUL4A KDM5B CCDC8 MYH9 ACACB CCT5 ZMYM2 SMARCC2 CDC5L RUVBL2 TP53

1.59e-055079011int:RBBP7
InteractionDYNLL1 interactions

HMBOX1 VIM MYH9 AKAP9 PPFIBP1 ZMYM2 PPP1R9B MTCL1 PDZRN3 GOLGB1 TP53

1.68e-055109011int:DYNLL1
InteractionBAG5 interactions

MYH9 ACACB CCT5 ATXN3 PLEC CDC5L RUVBL2 TP53 STAT5B

2.17e-05341909int:BAG5
InteractionPLEC interactions

VIM CCDC8 MYH9 MACF1 PPP1R9B PLEC CDC5L RAPGEF2 DNAH5 TP53

2.20e-054309010int:PLEC
InteractionPHF21A interactions

USP34 ACACB UBR5 ERC1 VPS50 LPXN ZMYM2 PLEC GOLGB1

2.27e-05343909int:PHF21A
InteractionCDC5L interactions

VIM MYH9 AKAP9 CCT5 UBR5 MDC1 INTS1 SMARCC2 MACF1 MTCL1 PLEC CDC5L RUVBL2 GOLGB1

2.48e-058559014int:CDC5L
InteractionPRC1 interactions

VIM KDM5B MYH9 RBM25 AKAP9 CCT5 MDC1 PES1 LMNB2 MTCL1 PLEC CDC5L RUVBL2 DDX27 GOLGB1

2.49e-059739015int:PRC1
InteractionSNRNP40 interactions

CUL4A RBM25 ACACB CCT5 UBR5 MDC1 SMARCC2 CDC5L RFC1 USP37 DDX27 CBX8

2.59e-056379012int:SNRNP40
InteractionWDR5 interactions

CUL4A MYH9 ACACB CCT5 UBR5 ZMYM2 SMARCC2 MACF1 LMNB2 PLEC KDM6B RUVBL2 DDX27 GOLGB1 CBX8 TP53

2.65e-0511019016int:WDR5
InteractionZBTB7A interactions

VIM UBR5 SMARCC2 RFC1 RUVBL2 TP53

2.68e-05131906int:ZBTB7A
InteractionGSK3B interactions

CUL4A VIM MYH9 ACACB UBR5 ERC1 PPFIBP1 ATXN3 MACF1 MICAL3 MTCL1 PLEC DKK3 TP53

2.93e-058689014int:GSK3B
InteractionMYH9 interactions

KIF13B VIM MYH9 PES1 ATXN3 MACF1 PPP1R9B MICAL3 PLEC CDC5L DNAH5 RUVBL2 TP53

2.93e-057549013int:MYH9
InteractionUSP15 interactions

VIM TAOK3 MYH9 RBM25 CCT5 ERC1 MDC1 ZMYM2 SMARCC2 RUVBL2 TP53

3.14e-055469011int:USP15
InteractionMECOM interactions

SMARCC2 GAS7 PPP1R9B PLEC CDC5L RFC1 RUVBL2 DDX27 TP53

3.17e-05358909int:MECOM
InteractionANK3 interactions

CUL4A PPFIBP1 TTLL4 PPP1R9B MICAL3 PLEC TP53

3.28e-05201907int:ANK3
InteractionCCDC8 interactions

CCDC8 UBR5 INTS1 SMARCC2 LAMC1 MACF1 LMNB2 PLEC RUVBL2 GOLGB1 TP53 LARGE1

3.44e-056569012int:CCDC8
InteractionIMP3 interactions

EVI5 LPXN L1TD1 DDX27 KLHL20 TP53

3.45e-05137906int:IMP3
InteractionYWHAE interactions

KIF13B VIM KDM5B CCDC8 AKAP9 ERC1 PPFIBP1 ATXN3 SMARCC2 MACF1 PPP1R9B CGNL1 CDC5L MLXIP RAPGEF2 RUVBL2 TP53

3.54e-0512569017int:YWHAE
InteractionPLEKHH1 interactions

CUL4A LPXN DKK3

3.77e-0515903int:PLEKHH1
InteractionACTA1 interactions

VIM MYH9 CCT5 GAS7 MACF1 PPP1R9B PLEC KLHL20 TP53

4.19e-05371909int:ACTA1
InteractionGSK3A interactions

RBM25 AKAP9 ACACB CCT5 UBR5 ERC1 PPFIBP1 MACF1 MICAL3 MTCL1

4.19e-054649010int:GSK3A
InteractionCDKN1A interactions

CUL4A VIM UBR5 PPFIBP1 ATXN3 CDC5L NMRK2 TP53 STAT5B

4.55e-05375909int:CDKN1A
InteractionRBBP4 interactions

CUL4A KDM5B CCDC8 ACACB ATXN3 ZMYM2 SMARCC2 CDC5L RUVBL2 TP53 STAT5B

4.86e-055739011int:RBBP4
InteractionHNRNPU interactions

VIM CCDC8 MYH9 UBR5 MDC1 ATXN3 GAS7 PPP1R9B CDC5L RFC1 RUVBL2 DDX27 GOLGB1 CBX8 TP53

5.06e-0510359015int:HNRNPU
InteractionNUPR1 interactions

VIM MYH9 RBM25 MDC1 PES1 MACF1 PPP1R9B LMNB2 PLEC CDC5L RUVBL2 TP53

5.09e-056839012int:NUPR1
InteractionCDK9 interactions

VIM MYH9 RBM25 CCT5 UBR5 INTS1 PPP1R9B PLEC CDC5L RUVBL2 DDX27 TP53

5.23e-056859012int:CDK9
InteractionTUBG1 interactions

CUL4A CCDC8 CCT5 UBR5 LAMC1 LMNB2 CDC5L KDM6B TP53

5.25e-05382909int:TUBG1
InteractionWDR76 interactions

CUL4A VIM MYH9 CCT5 INTS1 SMARCC2 LAMC1 PLEC RFC1

5.36e-05383909int:WDR76
InteractionVCP interactions

CUL4A VIM CCDC8 MYH9 RBM25 HAUS1 CCT5 UBR5 PPFIBP1 VPS50 ATXN3 SMARCC2 PPP1R9B LMNB2 PLEC RUVBL2 TP53 TBCD

5.47e-0514359018int:VCP
InteractionFZR1 interactions

CUL4A VIM USP34 CCDC8 RBM25 CCT5 UBR5 MDC1 MTCL1 CDC5L RFC1 USP37 RUVBL2 DDX27 DKK3 TP53

5.63e-0511729016int:FZR1
InteractionKIF20A interactions

VIM MYH9 RBM25 UBR5 PPFIBP1 MDC1 SMARCC2 MACF1 PPP1R9B CHD2 LMNB2 PLEC RUVBL2 DDX27 TP53

6.08e-0510529015int:KIF20A
InteractionGRWD1 interactions

CUL4A ACACB CCT5 UBR5 CDC5L RFC1 RUVBL2 DDX27 TP53

6.16e-05390909int:GRWD1
InteractionCIT interactions

VIM MYH9 RBM25 AKAP9 CCT5 ERC1 MDC1 PES1 INTS1 SMARCC2 MACF1 CHD2 LMNB2 PLEC CDC5L RUVBL2 TUBAL3 TP53

6.26e-0514509018int:CIT
InteractionADARB1 interactions

MYH9 RBM25 NOL12 MDC1 PES1 SMARCC2 PLEC RFC1 RUVBL2 DDX27

6.51e-054899010int:ADARB1
InteractionDUXB interactions

ACACB MDC1 ZMYM2

6.69e-0518903int:DUXB
InteractionSPEF2 interactions

VIM MYH9 PLEC

6.69e-0518903int:SPEF2
InteractionCHD4 interactions

CUL4A VIM CCDC8 MYH9 RBM25 MDC1 PES1 ZMYM2 SMARCC2 CDC5L RFC1 RUVBL2 DDX27 TP53

6.78e-059389014int:CHD4
InteractionNEIL3 interactions

VIM RBM25 PLEC RUVBL2 TP53

7.40e-0597905int:NEIL3
InteractionUTP14A interactions

VIM RBM25 PES1 CDC5L DDX27 KLHL20 TP53

7.70e-05230907int:UTP14A
InteractionCDC20 interactions

KDM5B CCT5 UBR5 MDC1 CDC5L USP37 TP53

8.58e-05234907int:CDC20
InteractionHSP90AB1 interactions

CUL4A CCDC8 MYH9 CCT5 ERC1 ATXN3 SMARCC2 PPP1R9B FHOD3 CHD2 CGNL1 CDC5L RUVBL2 TP53

8.68e-059609014int:HSP90AB1
InteractionMCPH1 interactions

VIM CCT5 MDC1 SMARCC2 RUVBL2

8.97e-05101905int:MCPH1
InteractionPOLDIP3 interactions

HMBOX1 CCDC8 UBR5 ATXN3 FYCO1 KLHL20 TP53

9.29e-05237907int:POLDIP3
InteractionCUL7 interactions

CCDC8 RBM25 CCT5 MDC1 PES1 MACF1 LMNB2 PLEC CDC5L RUVBL2 DDX27 GOLGB1 TP53

9.36e-058459013int:CUL7
InteractionTUBA4A interactions

CUL4A MYH9 HAUS1 CCT5 ATXN3 CDC5L DNAH5 RUVBL2 TUBAL3 TP53

9.51e-055129010int:TUBA4A
InteractionMDC1 interactions

HMBOX1 UBR5 MDC1 ATXN3 SMARCC2 MICAL3 CDC5L KLHL20 TP53

9.71e-05414909int:MDC1
InteractionMYO5B interactions

EVI5 CCDC8 MYH9 DKK3 TP53

9.85e-05103905int:MYO5B
InteractionYWHAH interactions

KIF13B VIM KDM5B CCDC8 EVC2 AKAP9 ERC1 PPFIBP1 MACF1 PPP1R9B MTCL1 CGNL1 PLEC MLXIP RAPGEF2

1.02e-0411029015int:YWHAH
InteractionSMC1A interactions

CUL4A CCDC8 UBR5 MDC1 CHD2 CDC5L RFC1 USP37 KLHL20

1.04e-04418909int:SMC1A
InteractionHDLBP interactions

VIM CCDC8 RBM25 CCT5 SMARCC2 MYH16 CHD2 CDC5L RFC1 RUVBL2 CBX8 TP53 STAT5B

1.05e-048559013int:HDLBP
InteractionNAA40 interactions

VIM MYH9 ACACB ERC1 PES1 ZMYM2 SPART MACF1 PPP1R9B CGNL1 CDC5L RFC1 GOLGB1 TP53

1.06e-049789014int:NAA40
InteractionCDC23 interactions

CUL4A CCDC8 MDC1 FHOD3 CDC5L USP37 TP53

1.06e-04242907int:CDC23
InteractionMIDN interactions

VIM MYH9 SUSD5 NOL12 PES1 LMNB2 PLEC CDC5L DDX27 TUBAL3 TP53

1.07e-046269011int:MIDN
InteractionPMS1 interactions

AKAP9 UBR5 CDC5L RFC1 TP53

1.08e-04105905int:PMS1
InteractionCHEK1 interactions

CUL4A KIF13B ATXN3 CDC5L RFC1 USP37 TP53

1.14e-04245907int:CHEK1
InteractionBRCA1 interactions

HMBOX1 MYH9 CCT5 UBR5 ERC1 MDC1 SMARCC2 PPP1R9B PLEC CDC5L RFC1 ALDH9A1 USP37 RUVBL2 TP53 LCMT1

1.19e-0412499016int:BRCA1
InteractionCYLD interactions

CUL4A VIM MYH9 CCT5 ERC1 PDP2 FYCO1 MTCL1 PLEC CDC5L RFC1 RUVBL2 TP53

1.22e-048689013int:CYLD
InteractionDCAF12 interactions

CUL4A ACACB CCT5 UBR5 TP53

1.23e-04108905int:DCAF12
InteractionBRD2 interactions

NOL12 MDC1 PES1 SMARCC2 CDC5L RFC1 RUVBL2 KLHL20 TP53

1.27e-04429909int:BRD2
InteractionBICD1 interactions

VIM UBR5 ERC1 PPFIBP1 CGNL1 MLXIP TP53

1.29e-04250907int:BICD1
InteractionORC2 interactions

ALKBH4 PES1 LMNB2 CDC5L TP53

1.34e-04110905int:ORC2
InteractionCHD3 interactions

HMBOX1 VIM KDM5B CCDC8 MYH9 RBM25 ZMYM2 SMARCC2 CDC5L RFC1 DDX27 TP53

1.35e-047579012int:CHD3
GeneFamilyEF-hand domain containing|Plakins

MACF1 PLEC

3.30e-048632939
GeneFamilyMyosin heavy chains

MYH9 MYH16

1.22e-03156321098
GeneFamilyDNA helicases

CHD2 RUVBL2

1.57e-03176321167
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

EVI5 USP34 KDM5B TAOK3 AKAP9 UBR5 ERC1 ZMYM2 SPART LAMC1 MACF1 MICAL3 MTCL1 RAPGEF2 KLHL20

2.12e-078569015M4500
CoexpressionLAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED

SEMA3A MYH9 TSHZ2 PPFIBP1

8.77e-0638904M39244
CoexpressionFAN_OVARY_CL11_MURAL_GRANULOSA_CELL

VIM CTNNAL1 AKAP9 TSHZ2 PPFIBP1 HS6ST1 LAMC1 MACF1 LCMT1

2.23e-05444909M41713
CoexpressionBLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP

CUL4A AKAP9 ZMYM2 SMARCC2 LAMC1 CHD2 CDC5L KLHL20

5.88e-05389908M6520
CoexpressionGSE22886_TCELL_VS_BCELL_NAIVE_DN

CTNNAL1 ENTPD1 ATXN3 LAMC1 MTCL1 LARGE1

6.33e-05198906M4426
CoexpressionTABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING

MYH9 RBM25 AKAP9 PPFIBP1 HS6ST1 MACF1 FHOD3 GOLGB1

6.43e-05394908MM3724
CoexpressionGSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP

CTNNAL1 PES1 CYP27A1 LPXN CHD2 RFC1

6.51e-05199906M9320
CoexpressionGSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_UP

CUL4A TMEM53 PES1 VPS50 PPP1R9B TP53

6.51e-05199906M6131
CoexpressionGSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP

MYH9 INTS1 ZMYM2 GAS7 RAPGEF2 STAT5B

6.69e-05200906M6090
CoexpressionTRAVAGLINI_LUNG_LYMPHATIC_CELL

SEMA3A TSHZ2 PPFIBP1 GAS7 LAMC1 DKK3

8.53e-05209906M41670
CoexpressionDITTMER_PTHLH_TARGETS_DN

CUL4A SEMA3A MYH9 RAPGEF2

1.00e-0470904M18667
CoexpressionAtlasdev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000

KDM5B CTNNAL1 AFAP1L2 PPFIBP1 HS6ST1 ENTPD1 GAS7 DAAM2 MICAL3 MTCL1 CGNL1 PLEC ALDH9A1 USP37 CBX8

4.07e-068809015gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000
ToppCellRV|World / Chamber and Cluster_Paper

AKAP9 ACACB PPFIBP1 FHOD3 MICAL3 PDZRN3 LARGE1

9.24e-08181917bbe1e6e59d8889bd37d6e8303116cbdcafca7236
ToppCell-Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

UBR5 ERC1 TTLL4 ZMYM2 PPP1R9B PDZRN3 LARGE1

1.20e-071889176468fa95ad0395395301115286f2d8c0df5d3882
ToppCell-Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

UBR5 ERC1 TTLL4 ZMYM2 PPP1R9B PDZRN3 LARGE1

1.20e-071889177a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell-Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

UBR5 ERC1 TTLL4 ZMYM2 PPP1R9B PDZRN3 LARGE1

1.20e-071889179cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCellControl-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class

SEMA3A VIM TSHZ2 PPFIBP1 GAS7 LAMC1 MICAL3

1.59e-07196917e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4
ToppCell5'-Adult-Appendix|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SEMA3A VIM TSHZ2 L1TD1 SPART LAMC1 KDM6B

1.59e-07196917a579211ef14f348d0c5a290553150222dfbf1515
ToppCellIPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class

KIF13B TSHZ2 ENTPD1 GAS7 MACF1 PDZRN3 DKK3

1.64e-07197917f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell(01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition

EVI5 RBM25 CTNNAL1 AKAP9 PPFIBP1 RFC1 GOLGB1

1.76e-07199917a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue

RBM25 EVC2 AKAP9 MACF1 CHD2 GOLGB1

3.53e-07135916ae2d3a42e567b5bade304c0caa497eb725be3565
ToppCell3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VIM CCDC8 CYGB LAMC1 DAAM2 PDZRN3

2.29e-06186916d3509a579871ba6a8c4edd6137b28f271c9dbe70
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

USP34 RBM25 MACF1 CHD2 RAPGEF2 GOLGB1

2.44e-06188916ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCellRV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper

ACACB PPFIBP1 FHOD3 MICAL3 PDZRN3 LARGE1

2.52e-061899165e80c47f63980904c4c1ff02c201b67b456a0974
ToppCellILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

KIF13B MYH9 RBM25 AKAP9 MLXIP GOLGB1

2.52e-061899162c8a2fb76ea002bac554bc1c761ce960b5e116e1
ToppCellPND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

VIM MYH9 AKAP9 MACF1 CGNL1 GOLGB1

2.59e-06190916d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCellRV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper

ACACB PPFIBP1 FHOD3 MICAL3 PDZRN3 LARGE1

2.59e-06190916fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCellTracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

VIM AFAP1L2 CATSPER4 GAS7 DAAM2 PDZRN3

2.84e-06193916549a0b750c860b615aff767ad04c9a9d20f802f0
ToppCell5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KIF13B VIM CTNNAL1 PPFIBP1 GAS7 DKK3

2.84e-06193916d5930f7bd9b299f792212d40a3272a37adf64a82
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

AKAP9 CATSPER4 CCDC110 MTCL1 CGNL1 GOLGB1

3.19e-061979163d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VIM MYH9 HS6ST1 CYGB LAMC1 DAAM2

3.29e-0619891609be07ebfc3e49c3858e9b74605b69cf4fc28b56
ToppCellLAM-Endothelial-LymEndo|Endothelial / Condition, Lineage and Cell class

SEMA3A CCT5 TSHZ2 PPFIBP1 GAS7 LAMC1

3.29e-06198916ba64b1c95dfaa995045239d412e725596f6c482e
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

USP34 RBM25 AKAP9 MACF1 CHD2 GOLGB1

3.39e-06199916f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VIM CTNNAL1 AFAP1L2 PPFIBP1 GAS7 DKK3

3.39e-06199916a76aa30fb264bdcbc0cb09113f814fc5a89e7319
ToppCell5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VIM CTNNAL1 AFAP1L2 PPFIBP1 GAS7 DKK3

3.48e-06200916363a8cebf2ace820661bcb87c7941f6671f8e5f3
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

USP34 RBM25 AKAP9 MACF1 CHD2 GOLGB1

3.48e-0620091612f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

RBM25 ENTPD1 MACF1 KDM6B GOLGB1

8.54e-06135915b7a792a7c0c22d8b703509f134115f0e394d7de0
ToppCellControl-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

MYH9 NBPF10 SPART MACF1 LARGE1

1.67e-051559150a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5
ToppCellLPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TMCO5A AFAP1L2 SUSD5 DAAM2 DKK3

1.72e-051569156365b69ede98bc866e996bc52736b00401aacf6f
ToppCellPND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SEMA3A CTNNAL1 TSHZ2 PPFIBP1 PLEC

2.67e-05171915686f95892c3909973c66c9a27159a070a068f175
ToppCellPND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SEMA3A CTNNAL1 TSHZ2 PPFIBP1 PLEC

2.67e-05171915f7ba03e7bdb687f93782c936c7b3374cc5b3b77c
ToppCellPND14-Endothelial-Endothelial_lymphatic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SEMA3A CTNNAL1 TSHZ2 PPFIBP1 PLEC

2.67e-05171915d0ac50071a3854d02113c455fcc940a6ec59bbb9
ToppCellPND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SEMA3A CTNNAL1 TSHZ2 PPFIBP1 PLEC

2.67e-05171915fbf8e9db00573adcada4b25730e191417b7c9999
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

AKAP9 MACF1 CHD2 KDM6B GOLGB1

2.67e-051719152e9a20f8980b78325c52065a9c14ab3656267c05
ToppCellControl-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)

MYH9 NBPF10 SPART MACF1 LARGE1

2.67e-05171915d18855b24aadea38fd1e4592f945cf15b85e05f1
ToppCell3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KIF13B VIM CTNNAL1 PPFIBP1 GAS7

2.75e-05172915bc3ed05fdd94d5e1f19285aea867b1453292baec
ToppCell3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EVI5 CTNNAL1 AQP7B GAS7 FHOD3

2.82e-05173915922356a5b4c84607318ac24d7caa2e235b72b066
ToppCell15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class

L1TD1 LAMC1 MTCL1 PDZRN3 DKK3

2.90e-05174915fa0681e91724b9a51ee28b214ea5aa14e62ba1a3
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MYH9 NBPF10 CYGB LAMC1 DAAM2

2.98e-0517591512f5fd83c7710fc0c77406f765d9cbd133433b8b
ToppCellkidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SEMA3A VIM TSHZ2 PPFIBP1 GAS7

3.15e-05177915227d4f423b00be2e0c5797e2c5275d342e69a0f4
ToppCellkidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SEMA3A VIM TSHZ2 PPFIBP1 GAS7

3.15e-0517791566ffa279147961080c104242a08b176e301d80e3
ToppCell5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SEMA3A VIM TSHZ2 PPFIBP1 DKK3

3.15e-05177915b1775e05c28883a15c56628028770bc59d3233fb
ToppCellkidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SEMA3A VIM TSHZ2 PPFIBP1 GAS7

3.15e-051779150cbf54608d2ba0a0500af142f2029fe5e118c3c2
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CTNNAL1 FHOD3 MICAL3 PLEC LARGE1

3.24e-05178915a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCellC_00|World / shred on cell type and cluster

RANBP17 RBM25 TSHZ2 MLXIP GOLGB1

3.32e-05179915da2dadc3266ffebd4a34ac61bfa05fddcadcde4c
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

GAS7 FHOD3 MICAL3 PDZRN3 DKK3

3.41e-0518091508ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CYGB GAS7 FHOD3 PDZRN3 DKK3

3.50e-051819159e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9
ToppCell10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue

USP34 UBR5 TSHZ2 MACF1 CHD2

3.50e-05181915f2315414e714ac86211546a935660c4be6e85f1b
ToppCellfacs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SEMA3A CTNNAL1 TSHZ2 PPFIBP1 LAMC1

3.60e-051829152cc434e46985c66fc36de05344a67aa96d90abc9
ToppCell3'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SEMA3A VIM TSHZ2 ENTPD1 DKK3

3.60e-0518291582d6f72649c7dd4d64a84a9795edebdef2f285d6
ToppCellfacs-Lung-24m-Endothelial-lymphatic_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SEMA3A CTNNAL1 TSHZ2 PPFIBP1 LAMC1

3.60e-051829150cde2775bdaaa2172499925bd59b0ac2d545eb27
ToppCellfacs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SEMA3A CTNNAL1 TSHZ2 PPFIBP1 LAMC1

3.60e-051829153e7457b2a70b45735fb75d6617b7f34cef28758e
ToppCellRV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper

ACACB PPFIBP1 FHOD3 MICAL3 PDZRN3

4.09e-0518791578cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCelldroplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CCDC8 CYGB GAS7 PDZRN3 DKK3

4.20e-05188915b382d18fb09fb2869f3c151efa71540a7f5ed229
ToppCellLV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper

ACACB PPFIBP1 FHOD3 MICAL3 PDZRN3

4.20e-051889150758b474457efa36488e0195f7357100f4b6a090
ToppCell5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TSHZ2 CYGB LAMC1 DAAM2 DNAH5

4.20e-05188915997dcfc4f08738ab398d8abc15e4fd2fc6619862
ToppCellRV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

MYH9 FHOD3 MICAL3 PDZRN3 LARGE1

4.31e-051899150a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCellP07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

CTNNAL1 TSHZ2 ENTPD1 CYGB PLEC

4.41e-05190915e1b721bb74561fe51c53328a0394c9954e489049
ToppCellRV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper

MYH9 FHOD3 MICAL3 USP37 LARGE1

4.41e-0519091593c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCellLV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper

ACACB PPFIBP1 FHOD3 PDZRN3 LARGE1

4.41e-05190915de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

SEMA3A TSHZ2 PPFIBP1 LAMC1 MICAL3

4.41e-051909156e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCellILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

SEMA3A EVC2 TSHZ2 PPFIBP1 DKK3

4.41e-051909159ce301841ce9486701fa28eb2a9929e35d476878
ToppCellP07|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

VIM ENTPD1 CYGB CGNL1 DKK3

4.41e-0519091538a613a9bca0ba040c3ada00286d1ce6f83ab23a
ToppCellfacs-Lung-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CYGB GAS7 LAMC1 MACF1 DKK3

4.53e-05191915094c9d3270fc1e487ccf10fb4936af5f081f6009
ToppCell368C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

SEMA3A TSHZ2 PPFIBP1 GAS7 DKK3

4.64e-05192915b016e229300c183e14c0e2bba494bf49c7899112
ToppCellprimary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

VIM ACACB NBPF10 DAAM2 CGNL1

4.64e-05192915f7e4509003d71f805b9d4587098e90d2897b6739
ToppCellLV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper

ACACB FHOD3 MICAL3 PDZRN3 LARGE1

4.64e-05192915ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

SEMA3A TSHZ2 PPFIBP1 GAS7 DKK3

4.64e-05192915ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9
ToppCell3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SEMA3A VIM TSHZ2 PPFIBP1 DKK3

4.64e-05192915ee9a23a4f00424a50bd7907cf3b12dc50027877e
ToppCellprimary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

VIM ACACB NBPF10 DAAM2 CGNL1

4.64e-05192915705ce805cb00a53793b57bcf466d0fbec590a83c
ToppCellrenal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

ERC1 MACF1 FHOD3 RAPGEF2 LARGE1

4.64e-05192915e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCellfacs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYP27A1 SPART MACF1 PDZRN3 DKK3

4.76e-05193915eba3c70701b051bc1ed1f4db9270cb27a77ffc3e
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VIM AFAP1L2 ENTPD1 CACNA1H CGNL1

4.76e-05193915f27e2be497745098b5269aa799dd3d5f62d78ba7
ToppCellMesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor

TSHZ2 GAS7 LAMC1 PDZRN3 DKK3

4.76e-05193915acad568621ed677031797b8c2e34dafea798d681
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TSHZ2 CYGB RFC1 PDZRN3 DKK3

4.76e-05193915f25bdd10ef531b8d8441ea84573078b4b1b0f105
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VIM AFAP1L2 ENTPD1 CACNA1H CGNL1

4.76e-051939154ccf984baebbb13ae916727137ce593fda7514a2
ToppCell3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VIM CCDC8 TSHZ2 CYGB SPART

4.87e-05194915e2db75f4de114631b8bda4e188f84446545538b7
ToppCellControl-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations)

VIM TSHZ2 GAS7 PDZRN3 DKK3

4.87e-0519491503a269f75a481ea54aea8e6444605db8d6df493d
ToppCellIPF-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class

MYH9 DAAM2 CACNA1H RAPGEF2 LARGE1

4.87e-051949153892b188f424ffb80f3c75a1b6709a21c1e1601d
ToppCelldroplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

USP34 KDM5B AKAP9 ERC1 MACF1

4.87e-05194915e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VIM MYH9 L1TD1 CYGB DAAM2

4.87e-051949157a7406c3b021aeafde423d20290c681c3e8ea0a6
ToppCellCOVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type

VIM EVC2 TSHZ2 GAS7 LAMC1

4.87e-05194915d91c9f2ec47319051fc398320693fddbe8bbd4d6
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MYH9 AFAP1L2 CYGB LAMC1 CACNA1H

4.87e-0519491578dcb9d48259afabe73b41c5508a73a8d62339a4
ToppCellRA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper

ACACB FHOD3 MICAL3 PDZRN3 LARGE1

4.87e-05194915c3535f7cc0076653c72db582047cff053c322397
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

AFAP1L2 CYGB DAAM2 CACNA1H DKK3

4.87e-051949153cffb5c58f6d5bd254f39ee9c41b7e1e4da0ff75
ToppCell(6)_Endothelial_cells-(6)_Endothelial-F_(Lymphatics)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)

SEMA3A PPFIBP1 GAS7 CGNL1 DKK3

4.87e-051949159441202d6fa2ffbef9277d48ae9bc98876c26ec5
ToppCellfacs-Skin-Anagen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYP27A1 SPART MACF1 PDZRN3 DKK3

4.87e-051949155d30d3d41d5f19cdf3077cc609aa2738762cb8c5
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

SEMA3A VIM TSHZ2 DAAM2 PDZRN3

4.87e-05194915a3e5a15cf6c1361207f661ee15eb634f77daf1cb
ToppCellCOVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type

AFAP1L2 SUSD5 DAAM2 CACNA1H PDZRN3

4.87e-051949155e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

SEMA3A TAOK3 TSHZ2 CYGB GAS7

4.99e-05195915c5d2d9f12fd893331c9de261af30607d845d4f6a
ToppCellIPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class

SEMA3A TSHZ2 PPFIBP1 GAS7 DKK3

4.99e-05195915de88e9d22044b4b3e29676ad02b3e9299cc920ad
ToppCell3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SEMA3A VIM TSHZ2 PPFIBP1 DKK3

4.99e-0519591536d4a11bc77a4cc97a22525c78ef8359f4a3ca66
ToppCellCOVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type

VIM EVC2 TSHZ2 GAS7 LAMC1

4.99e-05195915f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCell3'-GW_trimst-1-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VIM AFAP1L2 TSHZ2 DAAM2 CGNL1

4.99e-0519591519347b7e8d3ea67e0fddd948078abcab9d364a2d
ToppCell3'-GW_trimst-1-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VIM AFAP1L2 TSHZ2 DAAM2 CGNL1

4.99e-0519591555b4030f078173b0136990fae87b6eaf44c58f33
ToppCell343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

SEMA3A TSHZ2 PPFIBP1 GAS7 CGNL1

4.99e-05195915fc75f04eb475c8139cc5c35e6be22e73fb2be9e6
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TSHZ2 ENTPD1 LAMC1 PDZRN3 DKK3

4.99e-05195915a486a7acea0e91048cc48afa0dbd3926d30bc217
ToppCell343B-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

SEMA3A TSHZ2 PPFIBP1 GAS7 CGNL1

4.99e-0519591583d45ff5e5bc704448431149fffb2e4c1278f279
ToppCellcellseq-Mesenchymal-Myocytic-Myocytic_1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

AFAP1L2 CYGB DAAM2 CACNA1H DKK3

5.12e-05196915c373465e34e2dd581247962d59e0477aae877079
ToppCell3'-Adult-LymphNode-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SEMA3A VIM TSHZ2 PPFIBP1 DKK3

5.12e-05196915a2845436003e9adf34677eb81e78f8334ff01faa
ToppCellPCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

SEMA3A VIM TSHZ2 GAS7 PDZRN3

5.12e-051969158e10802f52e5e1853ea4ad34bf9a32a34e6112b5
ToppCell5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CYGB LAMC1 DAAM2 PDZRN3 DKK3

5.12e-051969152ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

MYH9 AKAP9 MACF1 CHD2 GOLGB1

1.16e-0549665GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
Drugirinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A

TAOK3 AKAP9 UBR5 ERC1 ZMYM2 MTCL1 RAPGEF2

5.27e-061719077535_DN
DrugEpirizole [18694-40-1]; Up 200; 17uM; PC3; HT_HG-U133A

SEMA3A USP34 NOL12 ZMYM2 CDC5L CBX8 LARGE1

1.29e-051969071803_UP
DrugSuccinylsulfathiazole [116-43-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A

VIM AKAP9 TTLL4 ENTPD1 ZMYM2 SPART SMARCC2

1.33e-051979072821_UP
DrugIfenprodil tartrate [23210-58-4]; Up 200; 8.4uM; HL60; HT_HG-U133A

EVI5 KIF13B ENTPD1 INTS1 SPART KDM6B TBCD

1.37e-051989072372_UP
DrugDeptropine citrate [2169-75-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A

USP34 AKAP9 NOL12 VPS50 MTCL1 KLHL20 STAT5B

1.37e-051989076523_DN
DrugSulfinpyrazone [57-96-5]; Up 200; 9.8uM; HL60; HG-U133A

EVI5 USP34 ACACB NOL12 SPART MLXIP KDM6B

1.37e-051989071574_UP
DrugHeptaminol hydrochloride [543-15-7]; Down 200; 22uM; MCF7; HT_HG-U133A

EVI5 RANBP17 KIF13B RBM25 ERC1 NOL12 RAPGEF2

1.42e-051999071703_DN
DrugGliclazide [21187-98-4]; Down 200; 12.4uM; HL60; HG-U133A

CUL4A EVI5 TMEM53 UBR5 SPART CDC5L KDM6B

1.47e-052009071720_DN
DrugAlprenolol hydrochloride [13707-88-5]; Down 200; 14uM; MCF7; HT_HG-U133A

USP34 TMEM53 PPFIBP1 ZMYM2 SMARCC2 PLEC TBCD

1.47e-052009076789_DN
Drugtamoxifen citrate; Up 200; 1uM; ssMCF7; HG-U133A

TMEM53 AKAP9 ENTPD1 ZMYM2 GAS7 CBX8 TBCD

1.47e-05200907375_UP
DrugMethamphetamine

RBM25 EVC2 ACACB CCT5 ASL TTLL4 CYP27A1 LPXN MACF1 MICAL3 ATP6V1C2 PLEC KDM6B GOLGB1 CBX8 TP53 LARGE1

3.04e-0514019017ctd:D008694
Drugmetoprolol

EVC2 NOL12 PES1 CYGB PPP1R9B

6.10e-05105905CID000004171
Drugirinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A

HMBOX1 TAOK3 UBR5 TTLL4 RAPGEF2 PDZRN3

6.69e-051749067530_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

USP34 RBM25 ZMYM2 PLEC CDC5L KLHL20

9.96e-051879064302_DN
DrugDiflunisal [22494-42-4]; Down 200; 16uM; HL60; HG-U133A

RBM25 ERC1 MACF1 RAPGEF2 KDM6B KLHL20

1.09e-041909061990_DN
Drugnocodazole

VIM MYH9 AKAP9 HAUS1 LMNB2 KDM6B GOLGB1 TUBAL3 TP53

1.13e-04477909CID000004122
DrugPindolol [13523-86-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A

KIF13B USP34 ACACB ENTPD1 VPS50 STAT5B

1.22e-041949062238_DN
DrugMecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A

KIF13B TMEM53 ENTPD1 MICAL3 LMNB2 KDM6B

1.25e-041959063525_DN
DrugMetyrapone [54-36-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A

VIM TMEM53 ERC1 CDC5L RAPGEF2 STAT5B

1.25e-041959065667_DN
Drugcox-2 inhibitor I; Up 200; 10uM; MCF7; HG-U133A

ALKBH4 TMEM53 UBR5 ZMYM2 CACNA1H PLEC

1.25e-04195906207_UP
DrugEdrophonium chloride [116-38-1]; Down 200; 19.8uM; PC3; HG-U133A

CUL4A KDM5B PPFIBP1 MACF1 RAPGEF2 KDM6B

1.29e-041969061936_DN
DrugZuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A

RANBP17 KIF13B TMEM53 ENTPD1 PLEC PDZRN3

1.29e-041969067356_DN
DrugAmikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A

KIF13B AKAP9 PPFIBP1 VPS50 KDM6B CBX8

1.29e-041969063233_DN
DrugMethylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A

KIF13B USP34 ACACB VPS50 GOLGB1 STAT5B

1.29e-041969063183_DN
DrugMolindone hydrochloride [15622-65-8]; Up 200; 12.8uM; MCF7; HT_HG-U133A

USP34 PPFIBP1 ENTPD1 CYP27A1 SMARCC2 CACNA1H

1.29e-041969067337_UP
DrugPregnenolone [145-13-1]; Down 200; 12.6uM; MCF7; HT_HG-U133A

EVI5 TMEM53 PPFIBP1 VPS50 MICAL3 KLHL20

1.29e-041969064802_DN
DrugChlorphensin carbamate [886-74-8]; Down 200; 16.2uM; HL60; HG-U133A

EVI5 ZMYM2 SPART MACF1 KDM6B KLHL20

1.29e-041969061432_DN
DrugCefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; HL60; HT_HG-U133A

USP34 ACACB VPS50 SPART KLHL20 TBCD

1.32e-041979062564_UP
DrugGuanadrel sulfate [22195-34-2]; Down 200; 7.6uM; PC3; HT_HG-U133A

USP34 ACACB ERC1 PPFIBP1 RAPGEF2 KDM6B

1.32e-041979067396_DN
DrugDemeclocycline hydrochloride [64-73-3]; Down 200; 8uM; HL60; HT_HG-U133A

ALKBH4 EVI5 TMEM53 TTLL4 PLEC KDM6B

1.32e-041979062545_DN
DrugCinoxacin [28657-80-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A

MYH9 FYCO1 CDC5L KDM6B TBCD STAT5B

1.32e-041979066257_DN
Drug1,1-dimethylbiguanide hydrochloride; Down 200; 0.1uM; MCF7; HG-U133A

VIM TMEM53 TSHZ2 INTS1 CHD2 RAPGEF2

1.32e-041979063_DN
DrugOxethazaine [126-27-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A

AKAP9 MICAL3 PLEC CDC5L TBCD STAT5B

1.32e-041979064829_DN
DrugTerbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A

USP34 TTLL4 INTS1 SMARCC2 MACF1 KLHL20

1.32e-041979066240_DN
DrugWY-14643; Up 200; 100uM; MCF7; HG-U133A

RANBP17 TMEM53 TSHZ2 SMARCC2 CHD2 KDM6B

1.36e-04198906487_UP
DrugClindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; PC3; HT_HG-U133A

EVI5 TMEM53 CYP27A1 CDC5L KLHL20 LARGE1

1.36e-041989062057_UP
DrugS(+)-Terguride [37686-84-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A

EVI5 VIM NOL12 RAPGEF2 KLHL20 STAT5B

1.36e-041989066459_DN
DrugFlucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A

TMEM53 ENTPD1 INTS1 ZMYM2 MICAL3 KLHL20

1.36e-041989065289_UP
DrugIsoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A

USP34 NOL12 CACNA1H RAPGEF2 KLHL20 STAT5B

1.36e-041989064789_UP
DrugTolnaftate [2398-96-1]; Up 200; 13uM; HL60; HG-U133A

CUL4A RBM25 TTLL4 CDC5L KDM6B KLHL20

1.40e-041999062001_UP
DrugSpaglumic acid [4910-46-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A

USP34 PPFIBP1 ENTPD1 LMNB2 TBCD STAT5B

1.40e-041999067465_UP
Drugbutirosin A from Bacillus vitellinus; Down 200; 10uM; PC3; HG-U133A

CTNNAL1 PPFIBP1 SMARCC2 GAS7 MACF1 DAAM2

1.44e-04200906666_DN
DrugAC1MMZLG

CTNNAL1 ASL DNAH5 TP53

1.45e-0467904CID003269220
DrugDocetaxel trihydrate

CCT5 CYP27A1 PLEC TUBAL3 CBX8 TP53

1.52e-04202906CID000003143
DiseasePR interval

SEMA3A KIF13B LAMC1 MACF1 LMNB2 PLEC CDC5L PDZRN3 CBX8

2.27e-05495919EFO_0004462
DiseaseCHARGE syndrome (implicated_via_orthology)

CHD2 TP53

1.96e-047912DOID:0050834 (implicated_via_orthology)
DiseaseCataract

VIM MYH9 INTS1

2.04e-0437913C0086543
Diseasecorpus callosum anterior volume measurement

SEMA3A LAMC1 PPP1R9B

2.39e-0439913EFO_0010295
DiseaseModerate albuminuria, diabetic nephropathy

CYGB CGNL1

2.60e-048912EFO_0000401, HP_0012594
Diseasecorpus callosum volume measurement

SEMA3A LAMC1 PPP1R9B PLEC

2.65e-04100914EFO_0010299
Diseaseneuroimaging measurement

SEMA3A TMCO5A CTNNAL1 LAMC1 MACF1 PLEC CDC5L RAPGEF2 PDZRN3 KLHL20 CBX8

4.49e-0410699111EFO_0004346
DiseaseIntellectual Disability

ENTPD1 ZMYM2 SMARCC2 MACF1 KDM6B TBCD LARGE1

4.73e-04447917C3714756
Diseasegastric adenocarcinoma (is_implicated_in)

UBR5 TP53

5.08e-0411912DOID:3717 (is_implicated_in)
DiseaseMyoclonic Astatic Epilepsy

CHD2 RAPGEF2

5.08e-0411912C0393702
DiseaseMyeloproliferative disease

ZMYM2 TP53

6.08e-0412912C0027022
Diseasevascular endothelial growth factor measurement

EVC2 MTCL1 CDC5L

6.99e-0456913EFO_0004762
DiseaseAdenocarcinoma Of Esophagus

SPART TP53

8.36e-0414912C0279628
DiseaseProfound Mental Retardation

ENTPD1 ZMYM2 KDM6B TBCD

9.18e-04139914C0020796
DiseaseMental Retardation, Psychosocial

ENTPD1 ZMYM2 KDM6B TBCD

9.18e-04139914C0025363
DiseaseMental deficiency

ENTPD1 ZMYM2 KDM6B TBCD

9.18e-04139914C0917816
Diseasecaffeine measurement

LAMC1 LMNB2

9.62e-0415912EFO_0021177
DiseaseT-Cell Lymphoma

TP53 STAT5B

1.10e-0316912C0079772
Diseaseosteosarcoma (is_implicated_in)

CDC5L TP53

1.10e-0316912DOID:3347 (is_implicated_in)
DiseaseFamilial Progressive Myoclonic Epilepsy

CHD2 LMNB2

1.24e-0317912C0751777
DiseaseAtypical Inclusion-Body Disease

CHD2 LMNB2

1.24e-0317912C0751776
DiseaseMyoclonic Epilepsies, Progressive

CHD2 LMNB2

1.24e-0317912C0751778
DiseaseBiotin-Responsive Encephalopathy

CHD2 LMNB2

1.24e-0317912C0751780
DiseaseMay-White Syndrome

CHD2 LMNB2

1.24e-0317912C0751782
DiseaseDentatorubral-Pallidoluysian Atrophy

CHD2 LMNB2

1.24e-0317912C0751781
Diseaseautism spectrum disorder (implicated_via_orthology)

KDM5B TAOK3 LAMC1 CHD2

1.28e-03152914DOID:0060041 (implicated_via_orthology)
DiseaseAction Myoclonus-Renal Failure Syndrome

CHD2 LMNB2

1.39e-0318912C0751779
Diseaseneuroimaging measurement, brain volume measurement

SEMA3A USP34 LAMC1 PPP1R9B PLEC

1.95e-03286915EFO_0004346, EFO_0006930
DiseaseGranulomatous Slack Skin

TP53 STAT5B

2.09e-0322912C0376407
Diseasecortical thickness

SEMA3A PPFIBP1 GAS7 LAMC1 MACF1 MICAL3 MTCL1 PLEC CDC5L CBX8

2.27e-0311139110EFO_0004840
DiseaseLymphoma, T-Cell, Cutaneous

TP53 STAT5B

2.28e-0323912C0079773
DiseaseQRS duration

USP34 UBR5 GAS7 FHOD3 PDZRN3

2.33e-03298915EFO_0005055
DiseaseKallmann Syndrome

SEMA3A HS6ST1

2.91e-0326912C0162809
Diseaseresponse to perphenazine

FHOD3 DKK3

2.91e-0326912GO_0097334
Diseasecolon adenocarcinoma (is_implicated_in)

UBR5 STAT5B

2.91e-0326912DOID:234 (is_implicated_in)
Diseaseosteoarthritis, hip

PLEC CDC5L MLXIP

2.92e-0392913EFO_1000786

Protein segments in the cluster

PeptideGeneStartEntry
TMERERALQELEEET

TMCO5A

71

Q8N6Q1
LARILAEFEMTLERD

BARGIN

116

Q6ZT62
TREEEAELVRLMDRD

ALKBH4

81

Q9NXW9
LDRMAESQEAELERL

AKAP9

611

Q99996
ARIIREREDEIATME

ALDH9A1

81

P49189
EDELEMLSEARARLA

CDC5L

146

Q99459
DELNMIVEEVRAIRF

CATSPER4

396

Q7RTX7
EESRRVDLELSIMEV

AFAP1L2

726

Q8N4X5
EVLILDEADRMLDEY

DDX27

366

Q96GQ7
LTRLLMVDLGEDEDE

RANBP17

671

Q9H2T7
AIEMEEDKRDLISRE

RBM25

266

P49756
ISSMERGLRDLEEEI

ERC1

391

Q8IUD2
DREELELEEVDLYRM

PDZRN3

411

Q9UPQ7
MLAEREEALEEADEL

NOL12

71

Q9UGY1
AEEEELLREMEELRS

MTCL1

331

Q9Y4B5
ERLLLEAMDELEVAF

ACACB

1566

O00763
FEMVRNEDDLELARR

DAAM2

331

Q86T65
ERESLEVRMREVEEE

LARGE1

61

O95461
ESELMIFARELELED

MICAL3

1911

Q7RTP6
EDSEEEVDFLSERRM

MDC1

166

Q14676
EDLLEVLSDIDEMSR

INTS1

2061

Q8N201
LDMRLYEEDDLDRLE

PPFIBP1

946

Q86W92
GFDEMRLELDQLEVR

FYCO1

231

Q9BQS8
AEDRIRELEEAMAGE

LMNB2

331

Q03252
EEDERKMVREFLAEF

AQP7B

31

A0A075B734
RTMVDRAEAERDVLF

ASL

141

P04424
DMEDEEADLRRAIQL

ATXN3

241

P54252
ETFIASEVEERRLRM

KDM6B

1116

O15054
TAEEQRLFLMDREER

FSIP2

221

Q5CZC0
LDVDDKVEELMRRDS

HMBOX1

156

Q6NT76
ELQDELMTIRLREAE

EVI5

561

O60447
SEIEDFLLELTRMES

MACF1

2466

O94854
FSLSEEELLRMRQEV

EVC2

841

Q86UK5
MEELDALLEELERST

LPXN

1

O60711
DSERMDFELLPDDER

KDM5B

676

Q9UGL1
EAMITDLEERLRREE

MYH9

1026

P35579
MRELDDTRASREEIL

MYH9

1651

P35579
ERFEMFRELNEALEL

TP53

336

P04637
LLRMESEELADRVLD

ENTPD1

136

P49961
EDTIRRIEELNDLDM

HS6ST1

331

O60243
MQEEARRLREEIEEL

MLXIP

776

Q9HAP2
ESEDRTIIMEDRLLG

PDP2

326

Q9P2J9
IRDIDERAMELLIDF

KLHL20

111

Q9Y2M5
ARLLAAFEEREREME

CBX8

51

Q9HC52
TLEVILERMEDFTDS

CTNNAL1

321

Q9UBT7
QEMDIDEILRLAETR

CHD2

991

O14647
MEARIAELEDRLESE

CGNL1

1151

Q0VF96
IESLIDRDYMERDKD

CUL4A

736

Q13619
GEMEIERRERSEELS

CYGB

6

Q8WWM9
VIDDFMTRLDQLRAE

CYP27A1

181

Q02318
RELRIQDMDFTDLGE

FHOD3

796

Q2V2M9
FEDRLKEAEREVMDL

LAMC1

1071

P11047
REDAELDAEIELEMA

CACNA1H

1871

O95180
EEEGRTLEDVARIME

CCDC8

46

Q9H0W5
LEDLERSLTEEMALR

DKK3

321

Q9UBP4
NDLIEFRIDAILEEM

DNAH5

821

Q8TE73
DGMKSREELFREVLE

NMRK2

171

Q9NPI5
EDDADREAQLLEMRL

KIF13B

1121

Q9NQT8
LRIRCEEEDVEMSED

RUVBL2

371

Q9Y230
EIEREREEMARLLSD

ATP6V1C2

256

Q8NEY4
RELMEDSRTEADEDR

SUSD5

221

O60279
RSYRLADEEEMEDLL

SLFN14

531

P0C7P3
AEVSRIESLEFLDEM

LCMT1

291

Q9UIC8
MEVEEREVLQDSLDR

NBPF10

3721

Q6P3W6
EDEEFARTLAMLDEE

RFC1

221

P35251
EMSEFIRERIKIEED

GAS7

236

O60861
ELDSIEAELTRRVDM

HAUS1

261

Q96CS2
VADMERRDVDFELIK

CCT5

196

P48643
ERQEREIETFDMESL

TAOK3

866

Q9H2K8
DFDLEDTMDVARRVE

STAT5B

756

P51692
LREGMEEAEFLEARE

TUBAL3

416

A6NHL2
DLEEVLLEEMTVFRE

SEMA3A

471

Q14563
FEELETIMDREREAL

SMARCC2

906

Q8TAQ2
VDFESEDMDVERALR

B4GALNT4

861

Q76KP1
RSIENERDTLEFEMR

CCDC110

751

Q8TBZ0
IDRTDDDIEQLLEFM

RAPGEF2

116

Q9Y4G8
QRTDVRLSEMLEEED

VPS50

181

Q96JG6
PEDDRELFEDLLRQM

SPART

316

Q8N0X7
RDLEKSTRLEEDAME

nan

16

Q8NFD4
EEEARLAALEEQRME

PES1

491

O00541
EVVLARDIERMVEAR

TMEM53

221

Q6P2H8
VEVERDNLAEDIMRL

VIM

171

P08670
ETLRRMEEEERLAEQ

PLEC

1476

Q15149
LEMDVRRFEDVSSEV

TSHZ2

821

Q9NRE2
DLESQISDMRERLEE

MYH16

106

Q9H6N6
RIEELEEELEAERAM

MYH16

306

Q9H6N6
IEIDFPRAAEELDME

ZMYM2

1006

Q9UBW7
DRMSEEELLAAVLEI

USP37

701

Q86T82
AEREVALERFRVIMD

TBCD

51

Q9BTW9
FIAQRPDMREEELED

USP34

2906

Q70CQ2
DVRILVEMEDEFSRR

TTLL4

1006

Q14679
DSLRARVDEAMELII

UBR5

2436

O95071
AEERVAELARDLVEM

GOLGB1

2701

Q14789
DLSSRMDILEERIDS

L1TD1

651

Q5T7N2
RVLEESELARKEEMD

PPP1R9B

781

Q96SB3